Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# Ventis Pharma: We provide physicians and surgeons with better pain relief solutions for their patients. We aim to improve Post-Operative Care with safer, more effective, and more Accessible Pain Management Formulations

## Sitemaps
[XML Sitemap](https://ventispharma.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [A Three Arm Clinical Trial](https://ventispharma.com/a-three-arm-clinical-trial/): A Three-arm Randomized Clinical Trial Comparing Continuous Femoral Plus Single-injection Sciatic Peripheral Nerve Blocks versus Periarticular Injection with Ropivacaine or Liposomal Bupivacaine for Patients Undergoing Total Knee Arthroplasty.Multimodal analgesia is standard practice for total knee arthroplasty;
however, the role of regional techniques in improved perioperative outcomes remains
unknown. The authors hypothesized that peripheral nerve blockade would result in lower pain
scores and opioid consumption than two competing periarticular injection solutions. Read More
- [United States Patents](https://ventispharma.com/united-states-patents/): EXTENDED DURATION LOCAL ANESTHETIC FORMULATIONAn extended duration anesthetic includes a short duration
local anesthetic in a dilute solution and a long duration local
anesthetic. The long duration local anesthetic is maintained
in a powdered form until the time of administration. Premeasured quantities of the dilute solution and powdered
long duration local anesthetic in a kit allow for quick
preparation of a solution with desired concentrations of both
short duration local anesthetic and long duration local anesthetic at the time of administration. Read More
- [ASRA and COA Conferences](https://ventispharma.com/asra-and-coa-conferences/): We are thrilled to share some exciting updates from Ventis Pharma’s recent participation in two prestigious medical conferences, the ASRA and COA conferences. These events have been pivotal in showcasing our groundbreaking product, the Endura-KT™, to a captivated audience of medical professionals. In this blog post, we will recap the highlights from these conferences and the promising prospects that lie ahead for Ventis Pharma.

## Pages
- [Accessibility statement](https://ventispharma.com/accessibility-statement/): Ventis Pharma is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards.
- [Dental Division](https://ventispharma.com/dental-division/): Ventis Pharma is dedicated to providing healthcare professionals with high-quality compounded preparations produced under Section 503B of the Federal Food, Drug, and Cosmetic Act. Our Dental Division focuses on offering products that meet the clinical needs of oral and maxillofacial practitioners seeking consistent quality and dependable performance.
- [Disclaimer](https://ventispharma.com/disclaimer/): This website is designed solely for informational and educational purposes.  It is essential to consult with a doctor of your choice regarding the information provided here. We make no guarantees or warranties about the accuracy of the information on this website, and it is not intended to provide specific medical, dental, or surgical advice. Ventis Pharma and this website take no responsibility for the content of hyperlinked sites, and the presence of such links does not imply any relationships or endorsements.
- [Products](https://ventispharma.com/products/): Enduracaine™ is a novel combination of three well-established and highly safe anesthetic agents. This unique formulation provides superior pain control where other approaches—such as bupivacaine products—have consistently fallen short.
- [Latest News](https://ventispharma.com/latest-news/)
- [Our Team](https://ventispharma.com/our-team/): Meet Tim Patrick, the visionary CEO of Ventis Pharma, whose remarkable track record encompasses building and successfully exiting two thriving pharmaceutical startups. With a career spanning over three decades, Mr. Patrick's expertise and astute leadership have propelled him as one of the true experts in the pharmaceutical industry.
- [Contact Us](https://ventispharma.com/contact-us/): Connect with us to learn how our pain management solutions can help physicians and surgeons improve post-operative care with safer, more effective, and more accessible treatment options.
- [About Us](https://ventispharma.com/about-us/): Ventis Pharma Corporation is a biopharmaceutical company focused on developing and Formulating innovative pain management therapies. We create solutions to treat patients with a variety of post-operative pain and pain syndromes.
- [Home](https://ventispharma.com/): Ventis Pharma Corporation strives to become a world leader in advancing pain management solutions. Our innovative, long-acting, low-toxicity Formulations are designed to reduce surgical pain and treat chronic pain conditions safely and effectively. By making our Formulations cost-effective and available throughout the world, we can improve the quality of life for all patients. Ventis Pharma has achieved this by developing Endura-KT, a safe, long-lasting, low-toxicity, patented anesthesia Formulations. Endura-KT is cost-efficient and may provide an effective alternative to opioids.